Insulin treatment improves liver histopathology and decreases expression of inflammatory and fibrogenic genes in a hyperglycemic, dyslipidemic hamster model of NAFLD. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.